title,time_published,url,ticker,relevance_score,ticker_sentiment_label,ticker_sentiment_score
"Bank of New York Mellon Posts Upbeat Earnings, Joins Archer Aviation, Rivian Automotive And Other Big Stocks Moving Higher On Friday - Bank of New York Mellon  ( NYSE:BK ) ",20240712T142717,https://www.benzinga.com/news/24/07/39750475/bank-of-new-york-mellon-posts-upbeat-earnings-joins-archer-aviation-rivian-automotive-and-other-big,EYPT,0.175221,Neutral,0.0
"Stocks That Hit 52-Week Lows On Tuesday - SoundHound AI  ( NASDAQ:SOUN ) , Sonnet BioTherapeutics  ( NASDAQ:SONN ) ",20221122T154845,https://www.benzinga.com/news/22/11/29825126/stocks-that-hit-52-week-lows-on-tuesday,EYPT,0.028072,Neutral,0.004783
"Cognyte Software  ( NASDAQ:CGNT ) , EyePoint Pharmaceuticals  ( NASDAQ:EYPT )  - Bragar Eagel & Squire, P.C. Is Investigating EyePoint, Olo, Cognyte, and the WWE and Encourages Investors to Contact the Firm",20220912T010000,https://www.benzinga.com/pressreleases/22/09/g28822689/bragar-eagel-squire-p-c-is-investigating-eyepoint-olo-cognyte-and-the-wwe-and-encourages-investors,EYPT,0.155451,Neutral,-0.055059
"Biotech Daily: Merck's Two Combo Cancer Trials Miss Main Goal, Approval For Sinovac's COVID-19 Shot For Youngest Kids, Alnylam Aces Protein Disorder Trial",20220803T141314,https://www.benzinga.com/general/biotech/22/08/28331170/biotech-daily-mercks-two-combo-cancer-trials-miss-main-goal-approval-for-sinovacs-covid-19-shot-f,EYPT,0.098659,Neutral,0.0
